Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation
Aim. To study the changes of the levels of cardiac biomarkers (N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity troponin I (hsTnI)) in patients with newly diagnosed multiple myeloma (MM) during programmatic treatment with bortezomib (VCd regimen).Material and methods. This p...
Saved in:
Main Authors: | E. V. Fomina (Author), S. A. Kardovskaya (Author), D. A. Budanova (Author), P. A. Markin (Author), S. A. Appolonova (Author), A. S. Lishuta (Author), Yu. N. Belenkov (Author), I. S. Ilgisonis (Author) |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assesment of Markers of Endothelial Dysfunction and Myocardial Stress in Patients with Hypertrophic Cardyomyopathy
by: F. M. Bogatyreva, et al.
Published: (2021) -
The Use of Enhanced External Counterpulsation in the Treatment of Patients with Coronary Artery Disease
by: K. S. Karaganov, et al.
Published: (2020) -
DIFFICULTIES IN DIAGNOSING SECONDARY ARTHROPATHY AND MAJOR CLINICAL SYNDROMES OF MYELOMA
by: N.I. MUSTAFAKULOVA, et al.
Published: (2018) -
Chemotherapy and chemoembolization of patients with oncopathology as a risk factor for the development of myocardial dysfunction
by: Saule Kubekova, et al.
Published: (2023) -
P01.15. Multiple Myeloma, chemotherapy and curcumin
by: Panutich E, et al.
Published: (2012)